Edition:
United Kingdom

Deciphera Pharmaceuticals Inc (DCPH.OQ)

DCPH.OQ on NASDAQ Stock Exchange Global Select Market

24.73USD
18 May 2018
Change (% chg)

$-1.00 (-3.89%)
Prev Close
$25.73
Open
$25.88
Day's High
$26.25
Day's Low
$24.62
Volume
18,275
Avg. Vol
45,697
52-wk High
$29.97
52-wk Low
$15.37

Latest Key Developments (Source: Significant Developments)

Deciphera Pharmaceuticals Reports Q1 Loss Per Share $0.66
Tuesday, 8 May 2018 

May 8 (Reuters) - Deciphera Pharmaceuticals Inc ::DECIPHERA PHARMACEUTICALS, INC. ANNOUNCES FIRST QUARTER 2018 FINANCIAL RESULTS.Q1 LOSS PER SHARE $0.66.Q1 EARNINGS PER SHARE VIEW $-0.65 -- THOMSON REUTERS I/B/E/S."STUDY IN 2(ND)-LINE GIST ON TRACK TO COMMENCE LATER THIS YEAR".  Full Article

Deciphera Pharmaceuticals Q3 loss $5.85 per share​
Tuesday, 14 Nov 2017 

Nov 14 (Reuters) - Deciphera Pharmaceuticals Inc : :Deciphera Pharmaceuticals Inc announces third quarter 2017 financial results and corporate highlights.Qtrly loss $5.85 per share​.Q3 earnings per share view $-0.61 -- Thomson Reuters I/B/E/S.  Full Article

New Leaf Venture reports 12.9 pct stake in Deciphera Pharmaceuticals
Wednesday, 11 Oct 2017 

Oct 11 (Reuters) - Deciphera Pharmaceuticals Llc :New Leaf Venture Management III LLC reports 12.9 percent stake in Deciphera Pharmaceuticals as of Oct 2 - SEC filing‍​.  Full Article

Viking Global Investors reports 8.1 pct passive stake in Deciphera Pharmaceuticals
Wednesday, 11 Oct 2017 

Oct 11 (Reuters) - Deciphera Pharmaceuticals Llc :Viking Global Investors LP reports 8.1 percent passive stake in Deciphera Pharmaceuticals LLC ‍​as of Oct 2 - SEC filing‍​.  Full Article

Deciphera Pharmaceuticals prices initial public offering of 7.5 mln shares at $17 per share
Thursday, 28 Sep 2017 

Sept 27 (Reuters) - :Deciphera Pharmaceuticals announces pricing of initial public offering.Deciphera Pharmaceuticals announced pricing of initial public offering of 7.5 million shares of stock at public offering price of $17 per share.  Full Article

BRIEF-Deciphera Pharmaceuticals Reports Q1 Loss Per Share $0.66

* DECIPHERA PHARMACEUTICALS, INC. ANNOUNCES FIRST QUARTER 2018 FINANCIAL RESULTS